Myocardial fatty acid imaging with 123i-labelled 9-methyl-branched pentadecanoic acid (9mpa) using spet

Nuclear Medicine Communications

Volumn 19, Issue 9, 1998, Pages 839-848

  Nakajima, Kenichi ^a   Taki, J ^a   Tonami, N ^a   Takata, S ^b   Shimizu, M ^b   Yamamoto, W ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

^b KANAZAWA UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

9 METHYL BRANCHED PENTADECANOIC ACID I 123; DECANOIC ACID DERIVATIVE; FATTY ACID; RADIOPHARMACEUTICAL AGENT; THALLIUM 201; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CORONARY ARTERY DISEASE; DRUG CLEARANCE; DRUG UPTAKE; FATTY ACID METABOLISM; FEMALE; HUMAN; IMAGE QUALITY; INTERMETHOD COMPARISON; INTRAVENOUS DRUG ADMINISTRATION; MALE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADULT; CORONARY DISEASE; FATTY ACIDS; FEMALE; HEART; HUMANS; IODINE RADIOISOTOPES; IODOBENZENES; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; MYOCARDIUM; REFERENCE VALUES; THALLIUM RADIOISOTOPES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0031762277     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-199809000-00004     Document Type: Article

References (21)

1. Goodmann MM, Kirsh G, Knapp FF Jr. Synthesis and evaluation of radioiodinated terminal p-iodophenyl-substi-tuted alpha-and beta-methyl-branched fatty acids. J Med Chem 1984; 27: 390-397.
2. Miller DD, Gill JB, Livni E et al. Fatty acid analogue accumulation: A marker of myocyte viability in ischemic-reperfused myocardium. Circ Res 1988; 63: 681-692.
3. Golsdstein RA, Klein MS, Welch MJ, Sobel BE. External assessment of myocardial metabolism with C-ll-palmitate in vivo. J Nucl Med 1980; 21: 342-348.
4. Lerch RA, Bergman SR, Ambos HD, Welch MJ, Ter-Pogossian MM, Sobel BE. Effect of flow-independent reduction of metabolism on regional myocardial clearance of C-ll palmitate. Circulation 1982; 65: 731-738.
5. Schwaiger M, Schelbert HR, Keen R et al. Retention and clearance of nC palmitic acid in ischemic and reperfused canine myocardium. J Am Coll Cardiol 1985; 6: 311-320.
6. Kennedy PL, Corbett JR, Kulkarni PV et al. Iodine-123-phenylpentadecanoic acid myocardial scintigraphy: Usefulness in identification of myocardial ischemia. Circulation 1986; 74: 1007-1015.
7. Van der Wall EE, Den Hollander W, Heindendal GAK, Wesera G, Majid PA, Roos JP. Dynamic myocardial scintigraphy with I-123-labeled free-fatty acids in patients with myocardial infarction. Eur J Nucl Med 1981; 6: 383-389.
8. Chouraqui P, Maddahi J, Henkin R, Karesh SM, Galie E, Berman DS. Comparison of myocardial imaging with iodine-123-iodophenyl-9-methyl pentadecanoic acid and thallium-201-chloride for assessment of patients with exercise induced myocardial ischemia. J Nucl Med 1991; 32: 447-452.
9. Knapp FF, Franken P, Kropp J. Cardiac SPECT with iodine-123-labeled fatty acids: Evaluation of myocardial viability with BMIPP. J Nucl Med 1995; 36: 1022-1030.
10. Fujibayashi Y, Nohara R, Hosokawa R et al. Metabolism and kinetics of iodine-123 BMIPP in canine myocardium. J Nucl Med 1996; 37: 757-761.
11. Nishimura T, Sago M, Kihara K et al. Fatty acid myocardial imaging using 123I-(J-methyl-iodophenyl pentadecanoic acid (BMIPP): Comparison of myocardial perfusion and fatty acid utilization in canine myocardial infarction (occlusion and reperfusion model). Eur J Nucl Med 1986; 12: 120-124.
12. Matsunari I, Saga T, Taki J et al. Kinetics of iodine-123-BMIPP in patients with prior myocardial infarction: Assessment with dynamic rest and stress images compared with stress thallium-201 SPECT. J Nucl Med 1994; 35: 1279-1285.
13. Nohara R, Okuda K, Ogono M et al. Evaluation of myocardial viability with iodine-123-BMIPP in a canine model. J Nucl Med 1996; 37: 1403-1407.
14. Taki J, Nakajima K, Matsunari I et al. Impairment of regional fatty acid uptake in relation to wall motion and thallium-201 uptake in ischaemic but viable myocardium: Assessment with iodine-123-labelled beta-methyl-bran-ched fatty acid. Eur J Nucl Med 1995; 22: 1385-1392.
15. Tateno M, Tamaki N, Yukihiro M et al. Assessment of fatty acid uptake in ischemic heart disease without myocardial infarction. J Nucl Med 1996; 37: 1981-1985.
16. Nakajima K, Shimizu K, Taki J et al. Utility of iodine-123-BMIPP in the diagnosis and follow-up of vasospastic angina. J Nucl Med 1995; 36: 1934-1940.
17. Tamaki N, Kawamoto M, Yonekura Y et al. Assessment of fatty acid metabolism using 1-123 branched fatty acid: A comparison with positron emission tomography. Ann Nucl Med 1993; 7: 41-47.
18. Taki J, Nakajima K, Matsunari L Assessment of myocardial fatty acid uptake and function after revascularization using iodine-123-BMIPP. J Nucl Med 1997; 38: 1503-1510.
19. Franken PR, Dendale P, De Geeter F, Demoor D, Bossuyt A, Block P. Prediction of functional outcome after myocardial infarction using BMIPP and sestamibi scintigraphy. J Nucl Med 1996; 37: 718-722.
20. Franken PR, De Geeter F, Dendale P, Demoor D, Block P, Blossuyt A. Abnormal free fatty acid uptake in subacute myocardial infarction after coronary thrombolysis: Correlation with wall motion and inotropic reserve. J Nucl Med 1994; 35: 1758-1765.
21. Inoue M, Kurosawa H, Tazawa S, Tamaki N, Yonekura Y. Myocardial fatty acid metabolism (beta oxidation) by radioiodinated 9MPA using myocardial ischemia model in rats (abstract). Jpn J Nucl Med (Kaku Igaku) 1997; 34: 627.